Colgate-Palmolive Company (NYSE:CL) went down by -0.26% from its latest closing price compared to the recent 1-year high of $86.41. The company’s stock price has collected -2.60% of loss in the last five trading sessions. Barron’s reported on 01/06/21 that Wall Street Is Souring on Coke. Now It’s Pepsi’s Turn.
Is It Worth Investing in Colgate-Palmolive Company (NYSE :CL) Right Now?
Colgate-Palmolive Company (NYSE:CL) scored a price-to-earnings ratio above its average ratio, recording 26.23 x from its present earnings ratio. Plus, the 36-month beta value for CL is at 0.60. Opinions of the stock are interesting as 10 analysts out of 23 who provided ratings for Colgate-Palmolive Company declared the stock was a “buy,” while 1 rated the stock as “overweight,” 8 rated it as “hold,” and 3 as “sell.”
The average price from analysts is $85.75, which is $2.36 above the current price. CL currently public float of 855.19M and currently shorts hold a 0.94% ratio of that float. Today, the average trading volume of CL was 3.52M shares.
CL’s Market Performance
CL stocks went down by -2.60% for the week, with a monthly drop of -3.08% and a quarterly performance of 2.97%, while its annual performance rate touched 17.09%. The volatility ratio for the week stands at 1.84% while the volatility levels for the past 30 days are set at 1.38% for Colgate-Palmolive Company. The simple moving average for the period of the last 20 days is -2.79% for CL stocks with a simple moving average of 7.20% for the last 200 days.
Analysts’ Opinion of CL
Many brokerage firms have already submitted their reports for CL stocks, with RBC Capital Mkts repeating the rating for CL by listing it as a “Sector Perform.” The predicted price for CL in the upcoming period, according to RBC Capital Mkts is $90 based on the research report published on January 04th of the current year 2021.
Wells Fargo, on the other hand, stated in their research note that they expect to see CL reach a price target of $80. The rating they have provided for CL stocks is “Underweight” according to the report published on December 08th, 2020.
Morgan Stanley gave a rating of “Equal-Weight” to CL, setting the target price at $78 in the report published on July 22nd of the previous year.
CL Trading at -2.31% from the 50-Day Moving Average
After a stumble in the market that brought CL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -4.94% of loss for the given period.
Volatility was left at 1.38%, however, over the last 30 days, the volatility rate increased by 1.84%, as shares sank -2.90% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +6.87% upper at present.
During the last 5 trading sessions, CL fell by -2.60%, which changed the moving average for the period of 200-days by +28.71% in comparison to the 20-day moving average, which settled at $84.38. In addition, Colgate-Palmolive Company saw -3.94% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at CL starting from Tsourapas Panagiotis, who sale 11,714 shares at the price of $85.27 back on Nov 18. After this action, Tsourapas Panagiotis now owns 4,676 shares of Colgate-Palmolive Company, valued at $998,889 using the latest closing price.
Wallace Noel R., the Chairman, President & CEO of Colgate-Palmolive Company, sale 21,446 shares at $85.86 during a trade that took place back on Nov 17, which means that Wallace Noel R. is holding 206,394 shares at $1,841,296 based on the most recent closing price.
Stock Fundamentals for CL
Current profitability levels for the company are sitting at:
- +23.97 for the present operating margin
- +59.12 for the gross margin
The net margin for Colgate-Palmolive Company stands at +15.08. The total capital return value is set at 48.22, while invested capital returns managed to touch 33.35.
Based on Colgate-Palmolive Company (CL), the company’s capital structure generated 7,250.43 points at debt to equity in total, while total debt to capital is 98.64. Total debt to assets is 56.43, with long-term debt to equity ratio resting at 6,687.18. Finally, the long-term debt to capital ratio is 90.98.
When we switch over and look at the enterprise to sales, we see a ratio of 4.29, with the company’s debt to enterprise value settled at 0.13. The receivables turnover for the company is 11.05 and the total asset turnover is 1.15. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.03.